Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023530 · ClinicalTrials.gov registry record · NA
Blood and Marrow Transplant Clinical Research Network
A NA study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- NA
- Development phase
NCT00023530: Completed NA study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00023530 is a NA study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00023530, a NA study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.
Interventions
- DRUG dexamethasone
- DRUG thalidomide
- DRUG fluconazole
- DRUG voriconazole
- PROCEDURE bone marrow transplant
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-09 |
| Est. Completion | 2006-08 |
| Phase | NA |
What the finished NCT00023530 record still lists
NCT00023530 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which dexamethasone is the first listed.
NCT00023530 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00023530 about?
NCT00023530 is a clinical study titled "Blood and Marrow Transplant Clinical Research Network". The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.
What is the current status of trial NCT00023530?
This trial is currently completed. It is a NA study. The study started on 2001-09. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00023530?
The interventions under investigation include: dexamethasone (DRUG), thalidomide (DRUG), fluconazole (DRUG), voriconazole (DRUG), bone marrow transplant (PROCEDURE).
Who is sponsoring clinical trial NCT00023530?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia